Cosciens Biopharma Inc

ET8

Company Profile

  • Business description

    Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing pharmaceutical and diagnostic products and active ingredients for the healthcare and cosmetics industries. It operates through two segments: Active Ingredient and Biopharmaceutical. The Active Ingredient segment, which generates maximum revenue, focuses on plant-based ingredients derived from oats and other renewable resources, including oat beta glucan, oat oil, and avenanthramides. The Biopharmaceutical segment focuses on the development and commercialization of therapeutics and diagnostic tests, including its product Macrilen, and advancing a pre-clinical pipeline targeting unmet medical needs, particularly in rare or orphan indications. It operates in Canada, Germany, the United States, and Austria.

  • Contact

    C/o Borden Ladner Gervais Llp
    Suite 3400, 22 Adelaide Street West
    TorontoONM5H 4E3
    CAN

    T: +1 843 900-3223

    E: [email protected]

    https://www.cosciensbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    28

Stocks News & Analysis

stocks

ASX property share lifts guidance despite sector headwinds

Aussie property manager lifts earnings expectations despite interest rate uncertainty.
stocks

Investors cheer Guzman dialing back global ambitions

Our view after US restaurants are closed.
stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,945.2066.700.75%
CAC 408,207.4534.340.42%
DAX 4025,337.88152.990.61%
Dow JONES (US)50,461.68118.02-0.23%
FTSE 10010,477.7013.69-0.13%
HKSE25,301.10298.35-1.17%
NASDAQ26,656.18312.211.19%
Nikkei 22564,999.413.320.01%
NZX 50 Index13,227.81158.071.21%
S&P 5007,519.1245.650.61%
S&P/ASX 2008,717.7065.500.76%
SSE Composite Index4,093.7351.65-1.25%

Market Movers